H
Haifa Maalmi
Researcher at Tunis University
Publications - 5
Citations - 248
Haifa Maalmi is an academic researcher from Tunis University. The author has contributed to research in topics: Vitamin D and neurology & Genotype. The author has an hindex of 5, co-authored 5 publications receiving 222 citations.
Papers
More filters
Journal ArticleDOI
The impact of vitamin D deficiency on immune T cells in asthmatic children: a case-control study
Haifa Maalmi,Anissa Berraies,E. Tangour,Jamel Ammar,Hanadi Abid,Kamel Hamzaoui,Agnes Hamzaoui +6 more
TL;DR: The findings suggest that vitamin D is an important promoter of T cell regulation in vivo in young asthmatics, and even in a southern Mediterranean country, hypovitaminosis D is frequent in children with asthma.
Journal ArticleDOI
Association of vitamin D receptor gene polymorphisms with susceptibility to asthma in Tunisian children: A case control study
TL;DR: This study shows a relation between VDR gene polymorphisms and susceptibility to asthma in children in Tunisian children and with serum vitamin D levels.
Journal ArticleDOI
IL-17A and IL-17F genes variants and susceptibility to childhood asthma in Tunisia
TL;DR: IL-17A and IL-17F are new pro-inflammatory cytokines implicated in neutrophilic inflammation and thus, involved in the pathogenesis of asthma and suggested to confer susceptibility to childhood asthma in Tunisia.
Journal ArticleDOI
Transcriptional characteristics of CD4+ T cells in young asthmatic children: RORC and FOXP3 axis
TL;DR: The TBX21/GATA-3 and RORC/FOXP3 ratios dysregulation in asthmatics is consistent with the plasticity existing between Th1, Th17, and Treg cells during inflammation.
Journal ArticleDOI
Association of IL-8 gene polymorphisms with non small cell lung cancer in Tunisia: A case control study.
Ahlem Rafrafi,Besma Chahed,Safa Kaabachi,Wajih Kaabachi,Haifa Maalmi,Kamel Hamzaoui,Fayçal Haj Sassi +6 more
TL;DR: The study indicated that IL-8 -251T allele was highly associated with large tumor size and high grade stage of NSCLC and the IL- 8 promoter polymorphism is associated with NSCLCs risk.